Integral Ad Science (IAS) Financials

$6.52 +0.11 (+1.72%)

Closing price 04:00 PM Eastern

Extended Trading

$6.67 +0.15 (+2.30%)

As of 04:05 PM Eastern

Annual Income Statements for Integral Ad Science

This table shows Integral Ad Science's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2019	2020	2021	2022	2023	2024
Net Income / (Loss) Attributable to Common Shareholders	-51	-32	-52	15	7.24	38
Consolidated Net Income / (Loss)	-51	-32	-52	15	7.24	38
Net Income / (Loss) Continuing Operations	-51	-32	-52	15	7.24	38
Total Pre-Tax Income	-67	-45	-56	13	4.86	55
Total Operating Income	-34	-14	-33	15	17	60
Total Gross Profit	180	200	269	340	375	416
Total Revenue	213	241	324	415	474	530
Operating Revenue	213	241	324	415	474	530
Total Cost of Revenue	33	41	55	76	99	114
Operating Cost of Revenue	33	41	55	76	99	114
Total Operating Expenses	214	214	302	317	358	356
Selling, General & Admin Expense	32	33	79	80	112	96
Marketing Expense	71	66	86	106	118	122
Research & Development Expense	40	49	67	76	73	70
Depreciation Expense	70	66	62	50	55	64
Other Operating Expenses / (Income)	-	0.64	0.65	4.75	0.43	3.93
Total Other Income / (Expense), net	-33	-32	-23	-9.05	-12	-5.36
Interest & Investment Income	-	-32	-	-9.05	-12	-5.36
Income Tax Expense	-15	-13	-3.54	-2.29	-2.38	17
Basic Earnings per Share	($0.39)	($0.24)	($0.37)	$0.10	$0.05	$0.23
Weighted Average Basic Shares Outstanding	131.61M	134.04M	143.54M	154.70M	156.27M	161.06M
Diluted Earnings per Share	($0.39)	($0.24)	($0.37)	$0.10	$0.04	$0.23
Weighted Average Diluted Shares Outstanding	131.61M	134.04M	143.54M	157.26M	161.72M	165.47M
Weighted Average Basic & Diluted Shares Outstanding	-	-	154.44M	154.42M	159.52M	163.80M

This table shows Integral Ad Science's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Net Income / (Loss) Attributable to Common Shareholders	0.77	11	3.15	7.68	-14	10	-1.26	7.69	16	15
Consolidated Net Income / (Loss)	0.77	11	3.15	7.68	-14	10	-1.26	7.69	16	15
Net Income / (Loss) Continuing Operations	0.77	11	3.15	7.68	-14	10	-1.26	7.69	16	15
Total Pre-Tax Income	2.05	4.12	6.17	-21	6.09	14	-1.39	13	19	25
Total Operating Income	-2.31	7.31	9.59	-18	9.20	17	0.54	14	20	26
Total Gross Profit	89	96	84	90	95	106	88	102	106	120
Total Revenue	108	117	106	114	120	134	115	129	134	153
Operating Revenue	108	117	106	114	120	134	115	129	134	153
Total Cost of Revenue	19	22	22	24	26	28	26	27	27	33
Operating Cost of Revenue	19	22	22	24	26	28	26	27	27	33
Total Operating Expenses	84	88	75	108	86	90	88	88	86	94
Selling, General & Admin Expense	20	24	21	42	23	26	21	25	25	24
Marketing Expense	28	28	26	32	30	30	32	30	30	31
Research & Development Expense	19	22	16	21	17	19	18	17	17	18
Depreciation Expense	13	13	13	14	14	15	15	16	16	17
Other Operating Expenses / (Income)	4.06	1.25	-0.52	-0.63	2.08	-0.50	1.57	0.32	-2.61	4.65
Total Other Income / (Expense), net	-2.62	-3.19	-3.42	-3.22	-3.11	-2.49	-1.93	-1.54	-1.33	-0.57
Income Tax Expense	1.29	-7.37	3.03	-29	20	3.86	-0.13	4.92	2.77	9.67
Basic Earnings per Share	$0.00	$0.08	$0.02	$0.05	($0.09)	$0.07	($0.01)	$0.05	$0.10	$0.09
Weighted Average Basic Shares Outstanding	155.39M	154.70M	154.32M	155.43M	157.06M	156.27M	159.39M	160.50M	161.66M	161.06M
Diluted Earnings per Share	$0.00	$0.08	$0.02	$0.05	($0.09)	$0.06	($0.01)	$0.05	$0.10	$0.09
Weighted Average Diluted Shares Outstanding	156.70M	157.26M	157.88M	162.63M	157.06M	161.72M	159.39M	163.75M	165.08M	165.47M
Weighted Average Basic & Diluted Shares Outstanding	153.83M	154.42M	154.93M	156.65M	157.85M	159.52M	160.54M	161.36M	162.67M	163.80M

This table details how cash moves in and out of Integral Ad Science's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2019	2020	2021	2022	2023	2024
Net Change in Cash & Equivalents	-13	23	24	17	38	-39
Net Cash From Operating Activities	-1.85	34	64	72	132	118
Net Cash From Continuing Operating Activities	-1.85	34	64	72	132	118
Net Income / (Loss) Continuing Operations	-51	-32	-52	15	7.24	38
Consolidated Net Income / (Loss)	-51	-32	-52	15	7.24	38
Depreciation Expense	70	66	62	50	55	64
Amortization Expense	1.27	1.37	1.14	0.46	0.46	0.46
Non-Cash Adjustments To Reconcile Net Income	3.22	2.76	64	39	80	55
Changes in Operating Assets and Liabilities, net	-25	-3.53	-12	-33	-11	-40
Net Cash From Investing Activities	-25	-9.66	-200	-18	-35	-41
Net Cash From Continuing Investing Activities	-25	-9.66	-200	-18	-35	-41
Purchase of Property, Plant & Equipment	-7.46	-9.66	-14	-17	-34	-41
Acquisitions	-18	0.00	-186	-1.60	-0.97	0.00
Net Cash From Financing Activities	14	-1.70	160	-37	-59	-116
Net Cash From Continuing Financing Activities	14	-1.70	160	-37	-59	-116
Repayment of Debt	-3.18	-1.53	-359	-37	-145	-120
Repurchase of Common Equity	-3.17	-0.17	-8.43	-24	0.00	0.00
Issuance of Debt	20	0.00	245	15	75	0.00
Issuance of Common Equity	0.00	0.00	282	0.85	3.16	3.21
Other Financing Activities, net	0.00	0.00	1.08	7.16	7.99	0.41
Cash Interest Paid	28	21	17	8.51	11	4.90
Cash Income Taxes Paid	1.16	1.42	2.24	16	11	35

This table details how cash moves in and out of Integral Ad Science's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Net Change in Cash & Equivalents	-0.62	11	7.52	4.21	-5.29	32	-40	-13	-15	29
Net Cash From Operating Activities	24	25	23	29	22	58	-1.13	26	25	68
Net Cash From Continuing Operating Activities	24	25	23	29	22	57	-1.13	26	27	66
Net Income / (Loss) Continuing Operations	0.77	11	3.15	7.68	-14	10	-1.26	7.69	16	15
Consolidated Net Income / (Loss)	0.77	11	3.15	7.68	-14	10	-1.26	7.69	16	15
Depreciation Expense	13	13	13	14	14	15	15	16	16	17
Amortization Expense	0.12	0.12	0.12	0.12	0.12	0.12	0.12	0.12	0.12	0.12
Non-Cash Adjustments To Reconcile Net Income	8.73	9.59	12	42	14	11	20	14	11	10
Changes in Operating Assets and Liabilities, net	2.13	-9.10	-5.57	-34	7.62	21	-35	-12	-16	23
Net Cash From Investing Activities	-4.28	-5.82	-8.34	-8.40	-8.76	-9.23	-10	-9.87	-10	-10
Net Cash From Continuing Investing Activities	-4.28	-5.82	-8.34	-8.40	-8.76	-9.23	-10	-9.87	-11	-9.07
Purchase of Property, Plant & Equipment	-4.29	-5.82	-8.34	-8.40	-8.76	-8.26	-10	-9.87	-11	-9.07
Net Cash From Financing Activities	-21	-8.28	-7.10	-17	-19	-17	-28	-29	-30	-29
Net Cash From Continuing Financing Activities	-21	-8.28	-7.10	-17	-19	-17	-28	-29	-30	-29
Repayment of Debt	-15	-9.98	-85	-20	-20	-20	-30	-30	-30	-30
Issuance of Common Equity	0.39	0.46	0.79	0.62	0.83	0.92	1.39	0.82	0.12	0.88
Other Financing Activities, net	2.53	1.25	2.12	2.88	0.59	2.41	0.31	-	-	0.10
Cash Interest Paid	2.52	2.96	3.00	2.86	3.02	2.35	1.88	1.74	1.00	0.29
Cash Income Taxes Paid	1.72	4.58	0.94	4.67	4.75	0.62	0.27	20	10	4.86

This table presents Integral Ad Science's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2020	2021	2022	2023	2024
Total Assets	850	1,130	1,169	1,192	1,152
Total Current Assets	130	170	221	265	254
Cash & Equivalents	52	73	87	125	84
Restricted Cash	0.19	0.07	0.05	0.05	0.51
Accounts Receivable	74	89	109	121	133
Prepaid Expenses	4.10	7.63	25	19	37
Plant, Property, & Equipment, net	2.24	1.41	2.41	3.77	4.00
Total Noncurrent Assets	718	958	945	923	893
Goodwill	459	677	674	675	673
Intangible Assets	256	276	241	219	195
Noncurrent Deferred & Refundable Income Taxes	0.00	0.89	2.02	2.47	1.68
Other Noncurrent Operating Assets	3.56	4.14	28	26	24
Total Liabilities & Shareholders' Equity	850	1,130	1,169	1,192	1,152
Total Liabilities	418	362	360	282	144
Total Current Liabilities	40	56	68	82	84
Accounts Payable	39	56	61	72	73
Current Deferred Revenue	1.14	0.16	0.10	0.68	1.06
Other Current Liabilities	-	0.00	6.87	9.56	10
Total Noncurrent Liabilities	378	306	293	200	59
Long-Term Debt	351	243	223	154	34
Capital Lease Obligations	-	-	-	20	13
Noncurrent Deferred & Payable Income Tax Liabilities	25	54	45	20	3.12
Other Noncurrent Operating Liabilities	0.00	8.68	24	6.18	8.71
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	431	767	808	909	1,008
Total Preferred & Common Equity	0.00	767	808	909	1,008
Preferred Stock	0.00	0.00	0.00	0.00	0.00
Total Common Equity	431	767	808	909	1,008
Common Stock	554	782	810	901	965
Retained Earnings	-127	-15	0.78	8.95	47
Accumulated Other Comprehensive Income / (Loss)	4.52	-0.32	-2.90	-0.92	-3.67

This table presents Integral Ad Science's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024
Total Assets	1,133	1,161	1,162	1,170	1,146	1,144	1,135
Total Current Assets	188	219	223	240	228	230	225
Cash & Equivalents	74	94	99	92	84	71	57
Restricted Cash	0.14	0.31	0.07	0.13	0.30	0.28	0.17
Accounts Receivable	93	103	113	129	111	121	130
Prepaid Expenses	21	21	12	19	32	38	38
Plant, Property, & Equipment, net	1.59	3.87	3.84	3.51	4.09	4.08	4.08
Total Noncurrent Assets	944	938	935	927	914	910	906
Goodwill	671	675	675	674	674	674	676
Intangible Assets	248	236	230	224	213	207	202
Noncurrent Deferred & Refundable Income Taxes	0.81	1.72	1.74	1.67	2.43	2.44	2.54
Other Noncurrent Operating Assets	23	26	28	27	24	26	26
Total Liabilities & Shareholders' Equity	1,133	1,161	1,162	1,170	1,146	1,144	1,135
Total Liabilities	358	334	284	292	221	197	152
Total Current Liabilities	51	55	59	69	53	61	61
Short-Term Debt	-	-	-	-	9.12	9.48	10
Accounts Payable	44	48	50	60	42	51	49
Current Deferred Revenue	0.29	0.62	0.43	0.24	1.32	0.56	1.45
Other Current Liabilities	6.86	6.39	8.00	9.07	0.08	0.00	0.00
Total Noncurrent Liabilities	307	279	225	223	168	135	92
Long-Term Debt	233	213	193	174	124	94	64
Capital Lease Obligations	-	-	-	-	18	18	16
Noncurrent Deferred & Payable Income Tax Liabilities	53	43	7.97	24	20	17	4.99
Other Noncurrent Operating Liabilities	21	23	24	25	6.17	6.17	6.19
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	775	828	878	879	925	948	982
Total Preferred & Common Equity	775	828	878	879	925	948	982
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	775	828	878	879	925	948	982
Common Stock	797	825	868	884	919	934	952
Retained Earnings	-11	4.86	13	-1.21	7.70	15	31
Accumulated Other Comprehensive Income / (Loss)	-12	-1.75	-1.97	-3.69	-1.98	-2.17	-1.28

This table displays calculated financial ratios and metrics derived from Integral Ad Science's official financial filings.

Metric	2019	2020	2021	2022	2023	2024
Growth Metrics	-	-	-	-	-	-
Revenue Growth	0.00%	12.72%	34.44%	28.38%	14.22%	11.75%
EBITDA Growth	0.00%	40.67%	-42.83%	117.08%	9.85%	72.11%
EBIT Growth	0.00%	58.92%	-137.82%	145.92%	12.77%	253.30%
NOPAT Growth	0.00%	58.92%	-137.82%	177.06%	43.07%	62.80%
Net Income Growth	0.00%	36.95%	-61.97%	129.32%	-52.92%	422.17%
EPS Growth	0.00%	38.46%	-54.17%	127.03%	-60.00%	475.00%
Operating Cash Flow Growth	0.00%	1,930.47%	87.39%	13.95%	81.63%	-10.43%
Free Cash Flow Firm Growth	0.00%	0.00%	69.10%	104.35%	21.91%	136.94%
Invested Capital Growth	0.00%	0.00%	28.15%	0.84%	1.41%	1.33%
Revenue Q/Q Growth	0.00%	0.00%	0.00%	3.74%	3.69%	3.67%
EBITDA Q/Q Growth	0.00%	0.00%	0.00%	8.32%	17.85%	10.00%
EBIT Q/Q Growth	0.00%	0.00%	0.00%	165.59%	116.63%	17.52%
NOPAT Q/Q Growth	0.00%	0.00%	0.00%	1,923.76%	361.27%	8.92%
Net Income Q/Q Growth	0.00%	0.00%	0.00%	1,744.17%	-15.44%	15.62%
EPS Q/Q Growth	0.00%	0.00%	0.00%	1,100.00%	-33.33%	15.00%
Operating Cash Flow Q/Q Growth	0.00%	0.00%	15.77%	-1.40%	32.92%	9.41%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	0.00%	0.00%	161.28%	260.01%
Invested Capital Q/Q Growth	0.00%	0.00%	0.00%	1.07%	-0.21%	-4.46%
Profitability Metrics	-	-	-	-	-	-
Gross Margin	84.49%	83.17%	83.13%	81.76%	79.06%	78.50%
EBITDA Margin	17.71%	22.11%	9.40%	15.90%	15.29%	23.55%
Operating Margin	-15.83%	-5.77%	-10.20%	3.65%	3.60%	11.39%
EBIT Margin	-15.83%	-5.77%	-10.20%	3.65%	3.60%	11.39%
Profit (Net Income) Margin	-24.05%	-13.45%	-16.21%	3.70%	1.53%	7.13%
Tax Burden Percent	76.89%	71.23%	93.68%	117.49%	149.05%	68.68%
Interest Burden Percent	197.66%	327.45%	169.57%	86.33%	28.41%	91.13%
Effective Tax Rate	0.00%	0.00%	0.00%	-17.49%	-49.05%	31.32%
Return on Invested Capital (ROIC)	0.00%	-2.66%	-2.77%	1.89%	2.68%	4.30%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	-17.79%	-15.28%	0.30%	-17.06%	-62.47%
Return on Net Nonoperating Assets (RNNOA)	0.00%	-12.35%	-5.98%	0.06%	-1.84%	-0.36%
Return on Equity (ROE)	0.00%	-15.01%	-8.75%	1.95%	0.84%	3.94%
Cash Return on Invested Capital (CROIC)	0.00%	-202.66%	-27.45%	1.06%	1.28%	2.98%
Operating Return on Assets (OROA)	0.00%	-1.63%	-3.34%	1.32%	1.45%	5.15%
Return on Assets (ROA)	0.00%	-3.81%	-5.30%	1.34%	0.61%	3.23%
Return on Common Equity (ROCE)	0.00%	-15.01%	-8.75%	1.95%	0.84%	3.94%
Return on Equity Simple (ROE_SIMPLE)	0.00%	0.00%	-6.83%	1.90%	0.80%	3.75%
Net Operating Profit after Tax (NOPAT)	-24	-9.72	-23	18	25	41
NOPAT Margin	-11.08%	-4.04%	-7.14%	4.29%	5.37%	7.82%
Net Nonoperating Expense Percent (NNEP)	0.00%	15.13%	12.51%	1.59%	19.74%	66.77%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	1.73%	2.35%	3.93%
Cost of Revenue to Revenue	15.51%	16.83%	16.87%	18.24%	20.94%	21.50%
SG&A Expenses to Revenue	15.05%	13.68%	24.42%	19.18%	23.53%	18.06%
R&D to Revenue	18.93%	20.36%	20.72%	18.38%	15.37%	13.18%
Operating Expenses to Revenue	100.32%	88.94%	93.34%	76.43%	75.45%	67.11%
Earnings before Interest and Taxes (EBIT)	-34	-14	-33	15	17	60
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	38	53	30	66	73	125
Valuation Ratios	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	0.63	4.46	1.67	2.50	1.68
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	151.79	12.10
Price to Revenue (P/Rev)	1.26	1.12	10.57	3.26	4.79	3.20
Price to Earnings (P/E)	0.00	0.00	0.00	87.96	313.83	44.93
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	1.14%	0.32%	2.23%
Enterprise Value to Invested Capital (EV/IC)	0.00	0.78	3.83	1.58	2.42	1.71
Enterprise Value to Revenue (EV/Rev)	0.00	2.37	11.09	3.58	4.89	3.13
Enterprise Value to EBITDA (EV/EBITDA)	0.00	10.71	118.00	22.55	31.99	13.31
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	98.20	135.73	27.50
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	83.59	91.06	40.05
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	16.78	56.43	20.54	17.63	14.09
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	149.46	191.08	57.74
Leverage & Solvency	-	-	-	-	-	-
Debt to Equity	0.00	0.81	0.32	0.28	0.19	0.05
Long-Term Debt to Equity	0.00	0.81	0.32	0.28	0.19	0.05
Financial Leverage	0.00	0.69	0.39	0.19	0.11	0.01
Leverage Ratio	0.00	1.97	1.65	1.46	1.37	1.22
Compound Leverage Factor	0.00	6.45	2.80	1.26	0.39	1.11
Debt to Total Capital	0.00%	44.89%	24.04%	21.64%	16.00%	4.51%
Short-Term Debt to Total Capital	0.00%	0.04%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	44.84%	24.04%	21.64%	16.00%	4.51%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	0.00%	55.11%	75.96%	78.36%	84.00%	95.49%
Debt to EBITDA	0.00	6.61	7.98	3.38	2.39	0.38
Net Debt to EBITDA	0.00	5.63	5.57	2.07	0.67	-0.30
Long-Term Debt to EBITDA	0.00	6.60	7.98	3.38	2.39	0.38
Debt to NOPAT	0.00	-36.17	-10.51	12.54	6.80	1.15
Net Debt to NOPAT	0.00	-30.82	-7.34	7.66	1.90	-0.90
Long-Term Debt to NOPAT	0.00	-36.13	-10.51	12.54	6.80	1.15
Altman Z-Score	0.00	0.53	5.95	2.81	5.47	7.97
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-
Current Ratio	0.00	3.21	3.01	3.26	3.21	3.02
Quick Ratio	0.00	3.10	2.88	2.90	2.98	2.58
Cash Flow Metrics	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	0.00	-741	-229	9.96	12	29
Operating Cash Flow to CapEx	-24.86%	351.24%	465.66%	434.22%	389.97%	290.79%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	-9.97	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	-0.06	0.00	2.77	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	-0.28	0.00	2.17	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-
Asset Turnover	0.00	0.28	0.33	0.36	0.40	0.45
Accounts Receivable Turnover	0.00	3.27	3.98	4.18	4.11	4.17
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	0.00	107.28	176.98	217.17	153.49	136.40
Accounts Payable Turnover	0.00	1.04	1.15	1.29	1.49	1.57
Days Sales Outstanding (DSO)	0.00	111.49	91.81	87.32	88.72	87.45
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	0.00	350.88	318.60	282.18	244.37	232.44
Cash Conversion Cycle (CCC)	0.00	-239.39	-226.79	-194.86	-155.64	-144.99
Capital & Investment Metrics	-	-	-	-	-	-
Invested Capital	0.00	731	937	945	958	971
Invested Capital Turnover	0.00	0.66	0.39	0.44	0.50	0.55
Increase / (Decrease) in Invested Capital	0.00	731	206	7.85	13	13
Enterprise Value (EV)	0.00	569	3,589	1,488	2,320	1,661
Market Capitalization	270	270	3,419	1,352	2,271	1,698
Book Value per Share	$0.00	$3.22	$4.98	$5.25	$5.76	$6.20
Tangible Book Value per Share	$0.00	($2.11)	($1.21)	($0.70)	$0.09	$0.86
Total Capital	0.00	783	1,010	1,031	1,083	1,056
Total Debt	0.00	351	243	223	173	48
Total Long-Term Debt	0.00	351	243	223	173	48
Net Debt	0.00	299	170	136	48	-37
Capital Expenditures (CapEx)	7.46	9.66	14	17	34	41
Debt-free, Cash-free Net Working Capital (DFCFNWC)	0.00	38	40	66	58	85
Debt-free Net Working Capital (DFNWC)	0.00	89	114	153	182	170
Net Working Capital (NWC)	0.00	89	114	153	182	170
Net Nonoperating Expense (NNE)	28	23	29	2.43	18	3.68
Net Nonoperating Obligations (NNO)	0.00	299	170	136	48	-37
Total Depreciation and Amortization (D&A)	72	67	63	51	55	64
Debt-free, Cash-free Net Working Capital to Revenue	0.00%	15.59%	12.49%	16.00%	12.15%	16.09%
Debt-free Net Working Capital to Revenue	0.00%	37.17%	35.14%	36.93%	38.46%	32.12%
Net Working Capital to Revenue	0.00%	37.03%	35.14%	36.93%	38.46%	32.12%
Earnings Adjustments	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	$0.00	($0.37)	$0.10	$0.05	$0.23
Adjusted Weighted Average Basic Shares Outstanding	0.00	0.00	143.54M	154.70M	156.27M	161.06M
Adjusted Diluted Earnings per Share	$0.00	$0.00	($0.37)	$0.10	$0.04	$0.23
Adjusted Weighted Average Diluted Shares Outstanding	0.00	0.00	143.54M	157.26M	161.72M	165.47M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	0.00	154.44M	154.42M	159.52M	163.80M
Normalized Net Operating Profit after Tax (NOPAT)	-24	-9.72	-18	11	12	41
Normalized NOPAT Margin	-11.08%	-4.04%	-5.71%	2.55%	2.52%	7.82%
Pre Tax Income Margin	-31.28%	-18.89%	-17.30%	3.15%	1.02%	10.38%
Debt Service Ratios	-	-	-	-	-	-
EBIT to Interest Expense	-1.02	0.00	-1.44	0.00	0.00	0.00
NOPAT to Interest Expense	-0.72	0.00	-1.01	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	-1.25	0.00	-2.03	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	-0.94	0.00	-1.60	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	-6.17%	-0.52%	-16.08%	153.87%	0.00%	0.00%

This table displays calculated financial ratios and metrics derived from Integral Ad Science's official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	37.09%	14.60%	18.88%	13.28%	11.08%	14.36%	7.95%	13.51%	10.97%	13.96%
EBITDA Growth	-31.56%	33.46%	40.95%	-123.60%	123.92%	54.27%	-30.17%	755.60%	56.55%	36.34%
EBIT Growth	-91.69%	441.38%	181.20%	-369.92%	498.66%	125.90%	-94.40%	177.70%	119.40%	54.52%
NOPAT Growth	-2.26%	1,461.26%	145.36%	-575.21%	-2,309.44%	-41.34%	-92.31%	167.68%	182.92%	30.52%
Net Income Growth	107.84%	338.20%	171.44%	291.48%	-1,892.57%	-11.51%	-139.89%	0.17%	217.02%	50.25%
EPS Growth	100.00%	366.67%	100.00%	400.00%	0.00%	-25.00%	-150.00%	0.00%	211.11%	50.00%
Operating Cash Flow Growth	429.46%	-3.98%	105.20%	142.22%	-9.46%	130.88%	-104.93%	-10.91%	15.40%	17.64%
Free Cash Flow Firm Growth	98.59%	0.00%	99.69%	79.73%	-253.80%	-110.89%	-1,443.35%	62.52%	15.76%	313.09%
Invested Capital Growth	1.32%	0.84%	0.83%	3.49%	2.71%	1.41%	4.76%	2.64%	5.84%	1.33%
Revenue Q/Q Growth	7.97%	8.41%	-9.66%	7.12%	5.88%	11.60%	-14.72%	12.64%	3.51%	14.61%
EBITDA Q/Q Growth	-46.19%	94.11%	11.34%	-120.29%	610.59%	33.73%	-49.60%	90.52%	21.93%	16.46%
EBIT Q/Q Growth	-134.21%	416.68%	31.19%	-289.89%	150.53%	79.45%	-96.75%	2,534.82%	42.67%	26.38%
NOPAT Q/Q Growth	-132.13%	2,467.15%	-76.04%	-360.78%	-62.92%	157.63%	-96.86%	2,194.89%	99.61%	-9.28%
Net Income Q/Q Growth	-60.89%	1,397.52%	-72.61%	144.02%	-279.09%	173.93%	-112.35%	712.75%	109.22%	-5.08%
EPS Q/Q Growth	-100.00%	0.00%	-75.00%	150.00%	-280.00%	166.67%	-116.67%	600.00%	100.00%	-10.00%
Operating Cash Flow Q/Q Growth	102.65%	2.27%	-7.83%	26.81%	-24.25%	160.77%	-101.97%	2,392.93%	-1.87%	165.83%
Free Cash Flow Firm Q/Q Growth	94.20%	196.33%	-123.08%	-1,471.93%	-1.23%	97.04%	-313.96%	61.82%	-127.52%	107.50%
Invested Capital Q/Q Growth	-0.58%	1.07%	0.20%	2.79%	-1.33%	-0.21%	2.50%	0.71%	1.74%	-4.46%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	82.30%	81.36%	79.56%	79.04%	78.73%	78.96%	77.16%	79.00%	79.50%	78.22%
EBITDA Margin	9.62%	17.23%	21.24%	-4.02%	19.40%	23.25%	13.74%	23.23%	27.37%	27.81%
Operating Margin	-2.13%	6.22%	9.04%	-16.02%	7.65%	12.29%	0.47%	10.97%	15.12%	16.67%
EBIT Margin	-2.13%	6.22%	9.04%	-16.02%	7.65%	12.29%	0.47%	10.97%	15.12%	16.67%
Profit (Net Income) Margin	0.71%	9.78%	2.97%	6.75%	-11.43%	7.57%	-1.10%	5.96%	12.05%	9.98%
Tax Burden Percent	37.34%	279.13%	50.97%	-35.82%	-225.69%	72.49%	90.35%	60.97%	85.30%	61.23%
Interest Burden Percent	-88.99%	56.30%	64.37%	117.69%	66.21%	84.93%	-258.66%	89.14%	93.44%	97.76%
Effective Tax Rate	62.66%	-179.13%	49.03%	0.00%	325.69%	27.51%	0.00%	39.03%	14.70%	38.77%
Return on Invested Capital (ROIC)	-0.34%	7.67%	2.11%	-5.22%	-8.34%	4.44%	0.16%	3.38%	6.68%	5.61%
ROIC Less NNEP Spread (ROIC-NNEP)	0.65%	1.84%	0.87%	11.11%	-2.50%	2.49%	-1.60%	2.09%	4.70%	-0.73%
Return on Net Nonoperating Assets (RNNOA)	0.14%	0.36%	0.15%	1.67%	-0.36%	0.27%	-0.17%	0.17%	0.29%	0.00%
Return on Equity (ROE)	-0.20%	8.03%	2.26%	-3.55%	-8.70%	4.71%	-0.01%	3.55%	6.96%	5.61%
Cash Return on Invested Capital (CROIC)	0.00%	1.06%	1.45%	-3.69%	-2.09%	1.28%	-4.07%	-2.23%	-1.82%	2.98%
Operating Return on Assets (OROA)	-0.77%	2.25%	3.38%	-6.20%	3.04%	4.94%	0.20%	4.74%	6.71%	7.54%
Return on Assets (ROA)	0.26%	3.54%	1.11%	2.61%	-4.54%	3.04%	-0.46%	2.58%	5.35%	4.51%
Return on Common Equity (ROCE)	-0.20%	8.03%	2.26%	-3.55%	-8.70%	4.71%	-0.01%	3.55%	6.96%	5.61%
Return on Equity Simple (ROE_SIMPLE)	-0.12%	0.00%	2.10%	2.63%	0.97%	0.00%	0.31%	0.30%	3.33%	0.00%
Net Operating Profit after Tax (NOPAT)	-0.86	20	4.89	-13	-21	12	0.38	8.63	17	16
NOPAT Margin	-0.80%	17.37%	4.61%	-11.22%	-17.26%	8.91%	0.33%	6.69%	12.90%	10.21%
Net Nonoperating Expense Percent (NNEP)	-0.99%	5.83%	1.25%	-16.33%	-5.83%	1.95%	1.76%	1.29%	1.97%	6.34%
Return On Investment Capital (ROIC_SIMPLE)	-	1.98%	-	-	-	1.11%	-	-	-	1.48%
Cost of Revenue to Revenue	17.70%	18.64%	20.44%	20.96%	21.27%	21.04%	22.84%	21.00%	20.50%	21.78%
SG&A Expenses to Revenue	18.60%	20.07%	19.53%	37.25%	18.79%	19.33%	18.67%	19.13%	18.98%	15.88%
R&D to Revenue	17.96%	18.97%	14.64%	18.57%	14.30%	14.19%	15.70%	13.56%	12.61%	11.47%
Operating Expenses to Revenue	77.99%	75.14%	70.52%	95.06%	71.08%	66.67%	76.69%	68.03%	64.38%	61.55%
Earnings before Interest and Taxes (EBIT)	-2.31	7.31	9.59	-18	9.20	17	0.54	14	20	26
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	10	20	23	-4.57	23	31	16	30	37	43
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.45	1.67	2.66	3.17	2.12	2.50	1.70	1.65	1.78	1.68
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	151.79	41.88	23.71	16.65	12.10
Price to Revenue (P/Rev)	2.82	3.26	5.10	6.25	4.07	4.79	3.26	3.13	3.41	3.20
Price to Earnings (P/E)	0.00	87.96	126.93	120.71	217.59	313.83	554.73	547.54	53.36	44.93
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	1.14%	0.79%	0.83%	0.46%	0.32%	0.18%	0.18%	1.87%	2.23%
Enterprise Value to Invested Capital (EV/IC)	1.38	1.58	2.45	2.96	2.03	2.42	1.65	1.61	1.75	1.71
Enterprise Value to Revenue (EV/Rev)	3.21	3.58	5.37	6.47	4.25	4.89	3.40	3.23	3.48	3.13
Enterprise Value to EBITDA (EV/EBITDA)	21.12	22.55	32.00	59.24	31.59	31.99	24.96	16.07	15.67	13.31
Enterprise Value to EBIT (EV/EBIT)	225.51	98.20	108.84	0.00	246.36	135.73	204.00	39.89	34.60	27.50
Enterprise Value to NOPAT (EV/NOPAT)	0.00	83.59	108.29	0.00	351.95	91.06	291.43	438.61	46.69	40.05
Enterprise Value to Operating Cash Flow (EV/OCF)	17.51	20.54	27.57	28.42	19.63	17.63	15.25	15.44	16.50	14.09
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	149.46	170.02	0.00	0.00	191.08	0.00	0.00	0.00	57.74
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.30	0.28	0.26	0.22	0.20	0.19	0.16	0.13	0.09	0.05
Long-Term Debt to Equity	0.30	0.28	0.26	0.22	0.20	0.19	0.15	0.12	0.08	0.05
Financial Leverage	0.21	0.19	0.17	0.15	0.15	0.11	0.11	0.08	0.06	0.01
Leverage Ratio	1.45	1.46	1.44	1.39	1.39	1.37	1.32	1.26	1.24	1.22
Compound Leverage Factor	-1.29	0.82	0.93	1.63	0.92	1.17	-3.40	1.13	1.16	1.19
Debt to Total Capital	23.12%	21.64%	20.49%	18.05%	16.50%	16.00%	14.01%	11.39%	8.45%	4.51%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.85%	0.89%	0.95%	0.00%
Long-Term Debt to Total Capital	23.12%	21.64%	20.49%	18.05%	16.50%	16.00%	13.16%	10.51%	7.50%	4.51%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	76.88%	78.36%	79.51%	81.95%	83.50%	84.00%	85.99%	88.61%	91.55%	95.49%
Debt to EBITDA	3.83	3.38	2.94	3.98	2.82	2.39	2.29	1.22	0.80	0.38
Net Debt to EBITDA	2.61	2.07	1.64	1.95	1.32	0.67	1.01	0.51	0.29	-0.30
Long-Term Debt to EBITDA	3.83	3.38	2.94	3.98	2.82	2.39	2.15	1.12	0.71	0.38
Debt to NOPAT	-238.78	12.54	9.95	-76.38	31.43	6.80	26.77	33.16	2.38	1.15
Net Debt to NOPAT	-163.21	7.66	5.53	-37.35	14.71	1.90	11.80	13.87	0.88	-0.90
Long-Term Debt to NOPAT	-238.78	12.54	9.95	-76.38	31.43	6.80	25.15	30.58	2.11	1.15
Altman Z-Score	2.37	2.79	4.54	6.41	4.42	5.47	4.89	5.44	7.60	7.87
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	3.67	3.26	4.01	3.80	3.47	3.21	4.32	3.76	3.71	3.02
Quick Ratio	3.26	2.90	3.61	3.60	3.20	2.98	3.70	3.13	3.08	2.58
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-13	13	-2.90	-46	-46	-1.37	-45	-17	-39	2.91
Operating Cash Flow to CapEx	568.38%	427.96%	275.19%	346.71%	251.88%	696.27%	-10.99%	262.80%	224.89%	745.93%
Free Cash Flow to Firm to Interest Expense	-4.98	0.00	-0.85	0.00	0.00	0.00	-23.22	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	9.30	0.00	6.72	0.00	0.00	0.00	-0.59	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	7.66	0.00	4.28	0.00	0.00	0.00	-5.93	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.36	0.36	0.37	0.39	0.40	0.40	0.42	0.43	0.44	0.45
Accounts Receivable Turnover	4.82	4.18	4.49	4.31	4.12	4.11	4.51	4.27	3.96	4.17
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	266.20	217.17	164.67	164.39	179.52	153.49	121.32	125.91	134.87	136.40
Accounts Payable Turnover	1.61	1.29	1.69	1.88	1.79	1.49	2.31	2.11	2.00	1.57
Days Sales Outstanding (DSO)	75.69	87.32	81.35	84.77	88.51	88.72	80.93	85.44	92.13	87.45
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	226.74	282.18	215.45	194.07	203.84	244.37	157.97	172.81	182.07	232.44
Cash Conversion Cycle (CCC)	-151.05	-194.86	-134.10	-109.30	-115.32	-155.64	-77.04	-87.37	-89.94	-144.99
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	935	945	946	973	960	958	991	999	1,016	971
Invested Capital Turnover	0.43	0.44	0.46	0.47	0.48	0.50	0.50	0.51	0.52	0.55
Increase / (Decrease) in Invested Capital	12	7.85	7.79	33	25	13	45	26	56	13
Enterprise Value (EV)	1,287	1,488	2,322	2,880	1,944	2,320	1,640	1,611	1,778	1,661
Market Capitalization	1,128	1,352	2,204	2,786	1,863	2,271	1,574	1,560	1,744	1,698
Book Value per Share	$4.98	$5.25	$5.36	$5.65	$5.61	$5.76	$5.80	$5.90	$6.09	$6.20
Tangible Book Value per Share	($0.93)	($0.70)	($0.53)	($0.17)	($0.13)	$0.09	$0.24	$0.41	$0.65	$0.86
Total Capital	1,008	1,031	1,041	1,072	1,052	1,083	1,076	1,069	1,073	1,056
Total Debt	233	223	213	193	174	173	151	122	91	48
Total Long-Term Debt	233	223	213	193	174	173	142	112	80	48
Net Debt	159	136	119	95	81	48	66	51	33	-37
Capital Expenditures (CapEx)	4.29	5.82	8.34	8.40	8.76	8.26	10	9.87	11	9.07
Debt-free, Cash-free Net Working Capital (DFCFNWC)	63	66	70	66	78	58	100	107	117	85
Debt-free Net Working Capital (DFNWC)	137	153	165	165	171	182	184	178	175	170
Net Working Capital (NWC)	137	153	165	165	171	182	175	169	164	170
Net Nonoperating Expense (NNE)	-1.63	8.92	1.74	-20	-7.02	1.80	1.63	0.94	1.13	0.35
Net Nonoperating Obligations (NNO)	159	136	119	95	81	48	66	51	33	-37
Total Depreciation and Amortization (D&A)	13	13	13	14	14	15	15	16	16	17
Debt-free, Cash-free Net Working Capital to Revenue	15.71%	16.00%	16.15%	14.74%	17.13%	12.15%	20.68%	21.51%	22.94%	16.09%
Debt-free Net Working Capital to Revenue	34.14%	36.93%	38.07%	36.94%	37.32%	38.46%	38.13%	35.74%	34.13%	32.12%
Net Working Capital to Revenue	34.14%	36.93%	38.07%	36.94%	37.32%	38.46%	36.24%	33.83%	32.13%	32.12%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	$0.08	$0.02	$0.05	($0.09)	$0.07	($0.01)	$0.05	$0.10	$0.09
Adjusted Weighted Average Basic Shares Outstanding	155.39M	154.70M	154.32M	155.43M	157.06M	156.27M	159.39M	160.50M	161.66M	161.06M
Adjusted Diluted Earnings per Share	$0.00	$0.08	$0.02	$0.05	($0.09)	$0.06	($0.01)	$0.05	$0.10	$0.09
Adjusted Weighted Average Diluted Shares Outstanding	156.70M	157.26M	157.88M	162.63M	157.06M	161.72M	159.39M	163.75M	165.08M	165.47M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	153.83M	154.42M	154.93M	156.65M	157.85M	159.52M	160.54M	161.36M	162.67M	163.80M
Normalized Net Operating Profit after Tax (NOPAT)	-1.62	5.12	4.89	-13	6.44	12	0.38	8.63	17	16
Normalized NOPAT Margin	-1.49%	4.36%	4.61%	-11.22%	5.35%	8.91%	0.33%	6.69%	12.90%	10.21%
Pre Tax Income Margin	1.90%	3.50%	5.82%	-18.86%	5.06%	10.44%	-1.21%	9.78%	14.13%	16.30%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-0.88	0.00	2.81	0.00	0.00	0.00	0.28	0.00	0.00	0.00
NOPAT to Interest Expense	-0.33	0.00	1.43	0.00	0.00	0.00	0.20	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	-2.52	0.00	0.36	0.00	0.00	0.00	-5.06	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	-1.97	0.00	-1.01	0.00	0.00	0.00	-5.15	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	-2,797.75%	153.87%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions About Integral Ad Science's Financials

When does Integral Ad Science's fiscal year end?

According to the most recent income statement we have on file, Integral Ad Science's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Integral Ad Science's net income changed over the last 5 years?

Integral Ad Science's net income appears to be on a downward trend, with a most recent value of $37.80 million in 2024, falling from -$51.35 million in 2019. The previous period was $7.24 million in 2023.

What is Integral Ad Science's operating income?

Integral Ad Science's total operating income in 2024 was $60.39 million, based on the following breakdown:

Total Gross Profit: $416.14 million
Total Operating Expenses: $355.76 million

How has Integral Ad Science revenue changed over the last 5 years?

Over the last 5 years, Integral Ad Science's total revenue changed from $213.49 million in 2019 to $530.10 million in 2024, a change of 148.3%.

How much debt does Integral Ad Science have?

Integral Ad Science's total liabilities were at $143.56 million at the end of 2024, a 49.1% decrease from 2023, and a 65.7% decrease since 2020.

How much cash does Integral Ad Science have?

In the past 4 years, Integral Ad Science's cash and equivalents has ranged from $51.73 million in 2020 to $124.76 million in 2023, and is currently $84.47 million as of their latest financial filing in 2024.

How has Integral Ad Science's book value per share changed over the last 5 years?

Over the last 5 years, Integral Ad Science's book value per share changed from 0.00 in 2019 to 6.20 in 2024, a change of 619.7%.

Related Companies

This page (NASDAQ:IAS) was last updated on 4/17/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Integral Ad Science (IAS) Financials

Frequently Asked Questions About Integral Ad Science's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Integral Ad Science (IAS) Financials

Annual Income Statements for Integral Ad Science

Quarterly Income Statements for Integral Ad Science

Annual Cash Flow Statements for Integral Ad Science

Quarterly Cash Flow Statements for Integral Ad Science

Annual Balance Sheets for Integral Ad Science

Quarterly Balance Sheets for Integral Ad Science

Annual Metrics and Ratios for Integral Ad Science

Quarterly Metrics and Ratios for Integral Ad Science

Frequently Asked Questions About Integral Ad Science's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools